No Data
Zomedica (ZOM.US) will release its financial report after the market closes on November 7th.
$Zomedica(ZOM.US)$ will release its financial report after the market closes on November 7th, investors please pay attention. How was its performance before? $Zomedica(ZOM.US)$ had $6.131 million in revenue and a net income of -$-23.931 million, with an EPS of -$0.024 in 2024/Q2. In 2023/Q3, the revenue was $6.347 million, net income was -$-0.491 million, and EPS was -$0.001. The above data was prepared under the US_GAAP accounting standards. Futubull reminder: 1. Hong Kong and US-listed companies use the same accounting standards.
Express News | Zomedica Releases The Ear Cytology Quick Scan Protocol, A New Feature Available On The TRUVIEW Microscope Equipped With The TRUprep Automated Slide Preparation System
Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 P.m. ET
Zomedica Corp (ZOM) Q2 2024 Earnings Call Highlights: Diagnostics Surge Amid Revenue Challenges
Zomedica Expands Distribution Agreement in Europe With Grovet
Zomedica Completes Renovation of Production Site in Minnesota
No Data
No Data
